Reference
- Baldwin T.O.; Holzman T.F.; Holzman R.B. Active center-based immunoassay approach using bacterial luciferase. Methods Enzymol. 1986, 133, 248–264.
- Bradford M.M. A rapid and sensitive for the quantitation of microgram quantitites of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72, 248–254.
- Elder R.O.; Keen J.E.; Siragusa G.R.; Barkocy-Gallagher G.A.; Koohmaraie M.; Laegreid W.W. Correlation of enterohemorrhagic Escherichia coli O157 prevalence in feces, hides and carcasses of beef cattle during processing. Proc. Natl. Acad. Sci. 2000(7), 2999–3003.
- Enouf V.; Langella P.; Commissaire J.; J., Cohen; Corthier G. Bovine Rotavirus Nonstructural protein 4 produced by Lactococcus lactis is antigenic and immunogenic. Appl. Environ. Microbiol. 2001, 67 (4), 1423–1428.
- Frankel G.; Phillips A.D.; Rosenshine G.D.; Kaper J.B.; Knutton S. Enteropathogenic and enterohemorrhagic Escherichia coli: more subversive elements. Mol. Microbiol. 1998, 30 (5), 911–921.
- Heijne V.G. The signal peptide. J. Membr. Biol. 1990, 115 (3), 195–201.
- Gabriela P.; Fuller R.; Raya R. Lactic acid bacteria and their effect on the immune system. Curr. Issues Intest. Microbiol. 2001, 2 (1), 27–42.
- Glenting J.; Madsen S.M.; Vrang A.; Fomsgaard A.; Israelsen H. A plasmid selection system in Lactococcus lactis and its use for gene expression in Lactococcus lactis and human kidney fibroblasts. Appl. Environ. Microbiol. 2002, 68 (10), 5051–5056.
- Grangette C.; Muller A. H.; Goudercourt D.; Geoffroy M.C.; Turneer M.; Mercenier A. Mucosal immune responses and protection against tetanus toxin after intranasal immunization with recombinant Lactobacillus plantarum. Infect. Immun. 2001, 69 (3): 1547–1553.
- Karmali M.A. Laboratory diagnosis of verotoxin-producing Escherichia coli infections. Clin. Microbiol. 1987, 9 (9), 65–70.
- Karmali M.A. Infection by verocytotoxin-producing Escherichia coli. Clin. Microbiol. Rev. 1989, 2 (1), 15–38.
- Knutton S.; Rosenshine I.; Pallen M. J.; Nisan I.; Neves B. C.; Bain C.; Wolff C.; Dougan G.; Frankel G. A novel EspA-associated surface organelle of enteropathogenic Escherichia coli involved in protein translocation into epithelial cells. EMBO 1998,17 (8), 2166–2176.
- Langella P., and Le L.Y. Heterologous protein secretion in Lactococcus lactis: a novel antigen delivery system. Braz. J. Med. Biol. Res. 1999, 32 (2), 191–198.
- Lee M.H.; Roussel Y.; Wilks M.; Tabaqchali S. Expression of helicobacter pylori urease subunit B gene in Lactococcus lactis MG1363 and its use as a vaccine delivery system against H. pylori infection in mice. Vaccine 2001, 19 (28), 3927-3935., 97
- Medaglini D.; Ciabattini A.; Spinosa M.R.; Maggi T.; Marcotte H.; Oggioni M.R.; Pozzi G. Immunization with recombinant Streptococcus gordonii expressing tetanus toxin fragment C confers protection from lethal challenge in mice. Vaccine 2001, 19 (15), 1931–1939.
- Miettinen M.; Vuopio-Varkila J.; Varkila K. Production of human tumor necrosis factor alpha, interleukin-6, and interleukin-10 is induced by lactic acid bacteria. Infect. Immun. 1996, 64 (12), 5403–5405.
- Norton P.M.; LePage R.W., and Wells J.M. Progress in the development of Lactococcus lactis as a recombinant mucosal vaccine delivery system. Folia Microbiol. 1995, 40 (3), 225–230.
- Perna N.T.; Mayhew G.F.; Posfia G.; Elliot S.; Donnenberg M.S.; Kaper J.B.; Blattner F.R. Molecular evolution of a pathogenicity island from enterohemorrhagic Escherichia coli O157:H7. Infect.Immun. 1998, 66 (8), 3810–3817.
- Pugsley A.P. The complete general secretary pathway in gram-negative bacteria. Microbiol. Rev. 1993, 57 (1), 50–108.
- Ruyter P.G.; Kuipers O.P., and Vos W.M. Controlled gene expression systems for Lactococcus lactis with the food-grade inducer nisin. Appl. Environ. Microbiol. 1996, 62 (10), 3662–3667.
- Sarah J.D.; Kocsis E.; Morris E.; Knutton S.; Booy F.P.; Frankel G. 3D structure of EspA filaments from enteropathogenic Escherichia coli. Mol. Microbiol. 2003, 49 (2), 301–308.
- Shaw R.K.; Daniell S.; Ebel F.; Frankel G.; Knutton S. EspA filament-mediated protein translocation into red blood cells. Cell microbiol. 2001, 3 (4), 213–222.
- Scheppler L., Vogel M., Zuercher A.W., Zuercher M., Germond J.E., Miescher S.M., Stadler B.M.: Recombinant Lactobacillus johnsonii as a mucosal vaccine delivery vehicle. Vaccine 2002, 20 (23), 2913–2920.
- Shu Q., and Gill H.S. Immune protection mediated by the probiotic Lactobacillus rhamnosus HN001 (DR20™) against Escherichia coli O157:H7 infection in mice. FEMS Immun. Med. Microbiol. 2002, 34 (1), 59–64.
- Wu C.Y.; Yang G.; Luis G.B.H.; Pang Q.F; Zeng Y.M.; Wang J.; Gao X.Y. Immunomodulatory effects of IL-12 secreted by Lactococcus lactis on Th1/Th2 balance in ovalbumin (OVA)-induced asthma model mice. Inter. immunophar. 2006, 6 (4), 610–615.
- Wu S.C.; Ye R.; Wu X.C.; Ng S.C.; Wong S.L. Enhanced secretory production of a single-chain antibody fragment from Bacillus subtilis by coproduction of molecular chaperones. J. Bacteriol. 1998, 180 (11), 2830–2835.
- Wu X.C.; Lee W.; Tran L.; Wong S.L. Engineering a Bacillus subtilis expression-secretion system with a strain deficient in six extracellular proteases. J. Bacteriol. 1991, 173 (16), 4952–4958.
- Zhuang Z., Wu Z.G., Chen M., and Wang P. G.: Secretion of human interferon- β 1b by recombinant Lactococcus lactis. Biotech. lett. 2008, 30 (10), 1819–1823.